Sarepta Therapeutics
SRPT
SRPT
328 hedge funds and large institutions have $5.04B invested in Sarepta Therapeutics in 2021 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 101 increasing their positions, 127 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 127
37% less first-time investments, than exits
New positions opened: 55 | Existing positions closed: 87
Holders
328
Holding in Top 10
3
Calls
$97M
Puts
$98.8M
Top Buyers
| 1 | +$200M | |
| 2 | +$56.2M | |
| 3 | +$47.9M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$43M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$36.3M |
Top Sellers
| 1 | -$255M | |
| 2 | -$105M | |
| 3 | -$52M | |
| 4 |
BlackRock
New York
|
-$50.3M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$32.3M |